Consejo Nacional de Salud

93 Morrison J, Swanton A, Collins S, Kehoe S. Chemotherapy
versus surgery for initial treatment
in advanced ovarian epithelial cancer. Cochrane
Database of Systematic Reviews 2007, Issue 4.
Art. No.: CD005343. DOI: 10.1002/14651858.
CD005343.pub2
94 Carrick S, Ghersi D, Wilcken N, Simes J. Platinum
containing regimens for metastatic breast
cancer. Cochrane Database of Systematic Reviews
2004, Issue 2. Art. No.: CD003374. DOI:
10.1002/14651858.CD003374.pub3.
95 GolfinopoulosV, Salanti G, Pavlidis N, Ioannidis J
PA, Survival benefits with diverse systemic treatment
regimens for advanced colorectal cancer:
meta-analysis of multiple treatments, Cochrane
Colloquium.
96 Singhal N, Singhal D. Adjuvant chemotherapy
for small intestine adenocarcinoma. Cochrane
Database of Systematic Reviews 2007, Issue 3.
Art. No.: CD005202. DOI: 10.1002/14651858.
CD005202.pub2
97 Dann E J, Bar-Shalom R, Tamir A, Haim N, Ben-
Shachar M, Avivi I, Zuckerman T, Kirschbaum M,
Goor O, Libster D, Rowe J M, Epelbaum R, Riskadapted
BEACOPP regimen can reduce the cumulative
dose of chemotherapy for standard and
high-risk Hodgkin lymphoma with no impairment
of outcome, BLOOD, 1 February 2007 _ Volume
109, Number 3 From Www.Bloodjournal.Org By
On November 19, 2008.
98 Micallef I N M, Kahl B S, Maurer MJ, Dogan
A, Ansell S M, Colgan J P, Geyer S, Inwards D
J, White W L, Habermann T M, A Pilot Study of
Epratuzumab and Rituximab in Combination With
Cyclophosphamide, Doxorubicin, Vincristine, and
Prednisone Chemotherapy in Patients With Previously
Untreated, Diffuse Large B-Cell Lymphoma,
CANCER December 15, 2006 / Volume 107 /
Number 12, 2828-32
99 Joensuu H, M.D., Kellokumpu-Lehtinen P-L, Bono
P et al, for the FinHer Study Investigators, Adjuvant
Docetaxel or Vinorelbine with or without
Trastuzumab for Breast Cancer N Engl J Med
2006;354:809-20.
100 Rubio-Martinez A, Recasens V, Odero M D,
Rubio-Felix D, Calasanz J, Mayayo P, Giralt M,
Giraldo P, CML and Imatinib Mesylate: Response
Related to Karyotype, Blood (ASH Annual Meeting
Abstracts) 2005 106: Abstract 4866
101 Sasse EC, Sasse AD, Brandalise SR, Clark OAC,
Richards S. Colony stimulating factors for prevention
of myelosupressive therapy induced febrile
neutropenia in children with acute lymphoblastic
leukaemia. Cochrane Database of Systematic Reviews
2005, Issue 3. Art. No.: CD004139. DOI:
10.1002/14651858.CD004139.pub2.
102 Jones AP, Davies SC, Olujohungbe A. Hydroxyurea
for sickle cell disease. Cochrane Database
of Systematic Reviews 2001, Issue 2. Art. No.:
CD002202. DOI: 10.1002/14651858.CD002202
103 Hurwitz H, Fehrenbacher L, Novotny W, Cartwright
T, Hainsworth J, Heim W, Berlin J, Baron
A, Griffing S, Holmgren E, Ferrara N, Fyfe G,
Rogers B, Ross R, Kabbinavar F, Bevacizumab
plus irinotecan, fluorouracil, and leucovorin for
metastatic colorectal cancer, The New England
Journal of Medicine ISSN 0028-4793 CODEN,
NEJMAG 2004, vol. 350, no23, pp. 2335-2342
104 Hind D, Wyld L, Beverley C, Reed MW. Surgery
versus primary endocrine therapy for operable
primary breast cancer in elderly women (70 years
plus). Cochrane Database of Systematic Reviews
2006, Issue 1. Art. No.: CD004272. DOI:
10.1002/14651858.CD004272.pub2.
105 Sharma R, Hamilton A, Beith J. LHRH agonists for
adjuvant therapy of early breast cancer in premenopausal
women. Cochrane Database of Systematic
Reviews 2008, Issue 4. Art. No.: CD004562. DOI:
10.1002/14651858.CD004562.pub3.
GRUPO L | Agentes antineoplásicos e inmunomoduladores
397
L